LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.20
-15.72%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 133 observations · as of Oct 30, 2026
1 month
-78.5%
3 months
-90.7%
6 months
-99.4%
1 year
-99.8%
Year to date
-99.8%
52-week range
$0.20 – $86.50
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$500K
P/E
-0.1
P/B
0.1
P/S
—
Revenue
$0
Net income
-$7.35M
Diluted EPS
-11.35
Gross margin
—
Net margin
—
Return on equity
1687.70%
Total debt
$101.62K
Cash
$2.58M
Free cash flow
—
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$3.77M | — | — | -$2.1M |
| Mar 31, 2026 | $0 | -$923.29K | — | — | -$349.69K |
| Dec 31, 2025 | $0 | -$744.92K | — | — | -$422.01K |
| Dec 31, 2025 | $0 | -$744.92K | — | — | -$422.01K |
| Sep 30, 2025 | $0 | -$1.91M | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent LABT news
All market newsNo ticker-linked stories are in the current archive.